Trial intelligence / Profile preview

Non-Invasive Assessment of Opioid Analgesia in Sickle Cell Disease

NCT00513864Phase 4Withdrawn

Sponsor
Children's National Research Institute
Start
Nov 2006
Primary completion
Mar 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of codeine in sickle cell disease (SCD), sponsored by Children's National Research Institute. Planned start Nov 2006; status: withdrawn.

02

Drugs

codeine
03

Conditions

sickle cell disease (SCD)

Beyond the preview

Go deeper on NCT00513864.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00513864.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call